-
Ovitex mesh for inguinal hernia
Anyone had experience with the ovitex mesh for inguinal hernia repair (OviTex IHR)? How is the recurrence rate compared with traditional permanent meshed? Is it as strong as the permanent meshed which has way more permanent material? Is there data on how long it takes for the biological part to be absorbed?
-
3 Replies
-
Most of the development work was done for ventral repairs. The product was introduced for the inguinal hernia repair market based on a 31 patient study by a single surgeon. There was a two year followup study done of 157 patients, but it was not a typical inguinal hernia mesh implantation method. The surgeon sutured the defect closed first then placed the mesh. So, it’s not really applicable to what a typical patient would get. It does look good for marketing purposes though. Good luck finding a good one-to-one comparison with synthetic mesh.
https://finance.yahoo.com/news/tela-bio-highlights-results-bravo-110000480.html
“Robotic Reinforced Biologic Augmented Repair (ReBAR) of Over 150 Inguinal Hernias: 2-Year Outcomes
AHS presentation on Wednesday, September 14th, 11:20-11:30 a.m.ET
This retrospective study examined the two-year recurrence rate of the robotic-assisted reinforced biologic augmented repair (ReBAR) of inguinal hernias from June 2018 to April 2022. All repairs employed the standard robotic transabdominal preperitoneal (rTAPP) approach combined with the novel ReBAR technique, which consists of suture closure of the defect followed by a biologic mesh reinforcement. After two years, only three recurrences were identified from the 157 inguinal hernias repaired using the ReBAR technique – a rate of 1.9%, and only two SSOs were identified in this cohort.”
finance.yahoo.com
24-Month BRAVO study results showed a 2.6% recurrence rate in diverse clinical scenarios Robotic Reinforced Biologic Augmented Repair (ReBAR) study showed a 1.9% recurrence rate at two-year mark MALVERN, Pa., Aug. 04, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: … Continue reading
-
It is still a very new product. But, really, it is not much different than any of the other biologic meshes.
The stock price has dropped dramatically since it went public at $13 per share even though the general stock market has increased dramatically. It’s just one of several of their products but there’s not much sign that it’s meeting its promises.
https://finance.yahoo.com/quote/TELA/
finance.yahoo.com
TELA Bio, Inc. (TELA) Stock Price, News, Quote & History - Yahoo Finance
Find the latest TELA Bio, Inc. (TELA) stock quote, history, news and other vital information to help you with your stock trading and investing.
-
Thanks for sharing. Any specific information about the mesh itself? Studies, research or anecdotal cases. I’m more interested in the outcome compared with permanent meshes, in terms of recurrence rate. Assuming mesh complication is not a concern. The hernia is rather small. Less than 1cm.
-
Log in to reply.